Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Deucravacitinib
Locations
2
United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
July 1, 2023
Primary Completion Date
December 1, 2024
Completion Date
January 31, 2025
Last Updated
April 7, 2026
NCT04459507
NCT05194839
NCT03972280
NCT03988335
Lead Sponsor
Brigham and Women's Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions